Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...

At 22, Daniel Cressy is making history as Louisiana’s first sickle cell gene therapy patient. The treatment could be a cure ...

With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial ...

Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Principal Investigator and Program Director of the NIH, ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...

Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), ...

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...

The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with ...

Krishnamurti helps bring a new federal program for expanding treatment access for Medicaid patients to Connecticut ...

Gene therapy appears to be a promising approach for a subset of genetic deafness, although challenges remain with development ...